Allen, J., Bergman, K., Bruinooge, S., Davis, A., Downs, C. G., Ferris, A., Fleury, M., Fredette, P., Hirsch, B., Hofacker, J., Lichtenfeld, L., Lubejko, B., Massett, H., McKee, A., Michaels, M., Minasian, L., Patrick-Lake, B., Purvis, J., & Puckrein, G. A. (2018). Barriers to Patient Enrollment in Therapeutic Clinical Trials for Cancer: A Landscape Report. https://www​.fightcancer​.org/sites/default​/files/Nationalpercent20Documents​/Clinical-Trials-Landscape-Report.pdf

Andring, L. M., Corrigan, K. L., Rooney, M., Bailard, N., Domingo, M., Fellman, B., Varkey, J., Foster-Mills, T., Kazantsev, T., Lin, L., Jhingran, A., Colbert, L., Eifel, P., Klopp, A. H., & Joyner, M. (2023). Patient Reported Outcomes for Women Undergoing Definitive Chemoradiation for Gynecologic Cancer: A Prospective Clinical Trial. Practical Radiation Oncology, S1879–8500(23)00224–2. 10.1016/j.prro.2023.07.004 [PubMed: 37597615] [CrossRef]

Bangs, R., & Crispino, T. (2019). From the other side: The patient perspective on cancer clinical trials. Urologic Oncology, 37(5), 331–335. 10.1016/j.urolonc.2018.01.003 [PubMed: 29428573] [CrossRef]

Barrett, N. J., Hawkins, T. V., Wilder, J., Ingraham, K. L., Worthy, V., Boyce, X., Reyes, R., Chirinos, M., Wigfall, P., Robinson, W., & Patierno, S. R. (2016). Implementation of a Health Disparities & Equity Program at the Duke Cancer Institute. Oncology Issues, 31(5), 48–57. 10.1080/10463356.2016.11884124 [CrossRef]

Bierer, B. E., White, S. A., Gelinas, L., & Strauss, D. H. (2021). Fair payment and just benefits to enhance diversity in clinical research. Journal of Clinical and Translational Science, 5(1), e159. 10.1017/cts.2021.816 [PMC free article: PMC8427546] [PubMed: 34527298] [CrossRef]

Blinder, V. S., Deal, A. M., Ginos, B., Jansen, J., Dueck, A. C., Mazza, G. L., Henson, S., Carr, P., Rogak, L. J., Weiss, A., Rapperport, A., Jonsson, M., Spears, P. A., Cella, D., Gany, F., Schrag, D., & Basch, E. (2023). Financial Toxicity Monitoring in a Randomized Controlled Trial of Patient-Reported Outcomes During Cancer Treatment (Alliance AFT-39). Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 41(29), 4652– 4663. 10.1200/JCO.22.02834 [PMC free article: PMC10564309] [PubMed: 37625107] [CrossRef]

Bodurtha Smith, A. J., Pena, D., & Ko, E. (2022). Insurance-Mediated Disparities in Gynecologic Oncology Care. Obstetrics and Gynecology, 139(2), 305–312. 10.1097/AOG.0000000000004643 [PMC free article: PMC8759538] [PubMed: 34991133] [CrossRef]

Borno, H. T., Zhang, L., Siegel, A., Chang, E., & Ryan, C. J. (2018). At What Cost to Clinical Trial Enrollment? A Retrospective Study of Patient Travel Burden in Cancer Clinical Trials. The Oncologist, 23(10), 1242–1249. 10.1634/theoncologist.2017-0628 [PMC free article: PMC6263122] [PubMed: 29700209] [CrossRef]

Borno, H. T., Zhang, L., Zhang, S., Lin, T. K., Skafel, A., Nieves, E., Dornsife, D., Johnson, R., Rhoads, K., Small, E., & Spicer, D. (2022). Implementation of a Multisite Financial Reimbursement Program in Cancer Clinical Trials Integrated With Patient Navigation: A Pilot Randomized Clinical Trial. JCO Oncology Practice, 18(6), e915–e924. 10.1200/OP.21.00328 [PMC free article: PMC9191303] [PubMed: 35196064] [CrossRef]

Borno, H. T., Zhang, S., Lin, T. K., Zhang, L., Palmer, N. R., Nguyen, C., Kaplan, C., & Ryan, C. J. (2022). Evaluating the impact of financial toxicity among cancer clinical trial participants. International Journal of Cancer Care and Delivery, 2(1). 10.53876/001c.30796 [CrossRef]

BrintzenhofeSzoc, K., Canin, B., Casas-Silva, E., Denicoff, A., Braun-Inglis, C., Okado, I., & Bakos, A. (2022). Through the Lens of Patient Partners: Challenges in Accrual of Older Adults to NCI Clinical Trials. Journal of the National Cancer Institute. Monographs, 2022(60), 125–134. 10.1093/jncimonographs/lgac022 [PMC free article: PMC9949584] [PubMed: 36519817] [CrossRef]

Brody, A. A., Convery, K. A., Kline, D. M., Fink, R. M., & Fischer, S. M. (2022). Transitioning to Remote Recruitment and Intervention: A Tale of Two Palliative Care Research Studies Enrolling Underserved Populations During COVID-19. Journal of Pain and Symptom Management, 63(1), 151–159. 10.1016/j.jpainsymman.2021.06.017 [PMC free article: PMC8685301] [PubMed: 34161811] [CrossRef]

Calderón, J. L., Baker, R. S., Fabrega, H., Conde, J. G., Hays, R. D., Fleming, E., & Norris, K. (2006). An Ethno-medical Perspective on Research Participation: A Qualitative Pilot Study. Medscape General Medicine, 8(2), 23. [PMC free article: PMC1785211] [PubMed: 16926762]

Caston, N. E., Lalor, F., Wall, J., Sussell, J., Patel, S., Williams, C. P., Azuero, A., Arend, R., Liang, M. I., & Rocque, G. B. (2022). Ineligible, Unaware, or Uninterested? Associations Between Underrepresented Patient Populations and Retention in the Pathway to Cancer Clinical Trial Enrollment. JCO Oncology Practice, 18(11), e1854–e1865. 10.1200/OP.22.00359 [PMC free article: PMC9653198] [PubMed: 36178922] [CrossRef]

Chino, F., Peppercorn, J. M., Rushing, C., Kamal, A. H., Altomare, I., Samsa, G., & Zafar, S. Y. (2017). Out-of-Pocket Costs, Financial Distress, and Underinsurance in Cancer Care. JAMA Oncology, 3(11), 1582–1584. 10.1001/jamaoncol.2017.2148 [PMC free article: PMC5824215] [PubMed: 28796862] [CrossRef]

Chino, F., Peppercorn, J. M., Rushing, C., Nicolla, J., Kamal, A. H., Altomare, I., Samsa, G., & Zafar, S. Y. (2018). Going for Broke: A Longitudinal Study of Patient-Reported Financial Sacrifice in Cancer Care. Journal of Oncology Practice. 10.1200/JOP.18.00112 [PMC free article: PMC6550053] [PubMed: 30138052] [CrossRef]

Chino, F., & Zafar, S. Y. (2019). Financial Toxicity and Equitable Access to Clinical Trials. American Society of Clinical Oncology Educational Book, 39, 11–18. 10.1200/EDBK_100019 [PubMed: 31099681] [CrossRef]

Cook, E. D., Arnold, K. B., Hermos, J. A., McCaskill-Stevens, W., Moody-Thomas, S., Probstfield, J. L., Hamilton, S. J., Campbell, R. D., Anderson, K. B., & Minasian, L. M. (2010). Impact of supplemental site grants to increase African American accrual for the Selenium and Vitamin E Cancer Prevention Trial. Clinical Trials (London, England), 7(1), 90–99. 10.1177/1740774509357227 [PMC free article: PMC3956599] [PubMed: 20156960] [CrossRef]

Coon, E. R., Schroeder, A. R., Lion, K. C., & Ray, K. N. (2022). Disparities by Ethnicity in Enrollment of a Clinical Trial. Pediatrics, 149(2), e2021052595. 10.1542/peds.2021-052595 [PubMed: 35043194] [CrossRef]

de Souza, J. A., Yap, B. J., Wroblewski, K., Blinder, V., Araújo, F. S., Hlubocky, F. J., Nicholas, L. H., O’Connor, J. M., Brockstein, B., Ratain, M. J., Daugherty, C. K., & Cella, D. (2017). Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer, 123(3), 476–484. 10.1002/cncr.30369 [PMC free article: PMC5298039] [PubMed: 27716900] [CrossRef]

Duma, N., Aguilera, J. V., Paludo, J., Haddox, C. L., Velez, M. G., Wang, Y., Leventakos, K., Hubbard, J. M., Mansfield, A. S., Go, R. S., & Adjei, A. A. (2017). Representation of Minorities and Women in Oncology Clinical Trials: Review of the Past 14 Years. Journal of Oncology Practice. 10.1200/JOP.2017.025288 [PubMed: 29099678] [CrossRef]

Ejem, D. B., Wechsler, S., Gallups, S., Khalidi, S., Coffee-Dunning, J., Montgomery, A. P., Stevens, C. J., Keene, K., Rocque, G. B., Chamberlin, M., Hegel, M. T., Azuero, A., Pisu, M., Ellis, D., Ingram, S. A., Lawhon, V. M., Gilbert, T., Morrissette, K., Morency, J., … Lyons, K. D. (2023). Enhancing Efficiency and Reach Using Facebook to Recruit Breast Cancer Survivors for a Telephone-Based Supportive Care Randomized Trial During the COVID-19 Pandemic. JCO Oncology Practice, 19(11), 1020–1030. 10.1200/OP.23.00117 [PMC free article: PMC10667016] [PubMed: 37733975] [CrossRef]

Ellis, S. D., Carpenter, W. R., Minasian, L. M., & Weiner, B. J. (2012). Effect of state-mandated insurance coverage on accrual to community cancer clinical trials. Contemporary Clinical Trials, 33(5), 933–941. 10.1016/j.cct.2012.06.001 [PMC free article: PMC3408810] [PubMed: 22683991] [CrossRef]

Gafford, J. A., Gurley-Calvez, T., Krebill, H., Lai, S. M., Christiadi, & Doolittle, G. C. (2017). Expanding Local Cancer Clinical Trial Options: Analysis of the Economic Impact of the Midwest Cancer Alliance in Kansas. Academic Medicine, 92(9), 1274–1279. 10.1097/ACM.0000000000001612 [PMC free article: PMC5574436] [PubMed: 28253204] [CrossRef]

Gerber, D. E., Lakoduk, A. M., Priddy, L. L., Yan, J., & Xie, X.-J. (2015). Temporal Trends and Predictors for Cancer Clinical Trial Availability for Medically Underserved Populations. The Oncologist, 20(6), 674–682. 10.1634/theoncologist.2015-0083 [PMC free article: PMC4571795] [PubMed: 26018661] [CrossRef]

Gerber, D. E., Tiro, J. A., McNeill, L. H., Williams, E. L., Zhu, H., Lee, S. J. C., Leavey, P. J., Sadeghi, N., Kapinos, K. A., Dornsife, D. L., Nguyen, V., Wileyto, E. P., & Guerra, C. E. (2022). Enhancing access to and diversity in cancer clinical trials through a financial reimbursement program: Protocol to evaluate a novel program. Contemporary Clinical Trials, 121, 106922. 10.1016/j.cct.2022.106922 [PubMed: 36096281] [CrossRef]

Gharzai, L. A., & Jagsi, R. (2023). Incorporating financial toxicity considerations into clinical trial design to facilitate patient-centered decision-making in oncology. Cancer, 129(8), 1143–1148. 10.1002/cncr.34677 [PubMed: 36775839] [CrossRef]

Giuliano, A. R., Mokuau, N., Hughes, C., Tortolero-Luna, G., Risendal, B., Ho, R. C. S., Prewitt, T. E., & Mccaskill-Stevens, W. J. (2000). Participation of Minorities in Cancer Research: The Influence of Structural, Cultural, and Linguistic Factors. Annals of Epidemiology, 10(8, Supplement 1), S22–S34. 10.1016/s1047-2797(00)00195-2 [PubMed: 11189089] [CrossRef]

Guerra, C. E., Fleury, M. E., Byatt, L. P., Lian, T., & Pierce, L. (2022). Strategies to Advance Equity in Cancer Clinical Trials. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting, 42, 1–11. 10.1200/EDBK_350565 [PubMed: 35687825] [CrossRef]

Hamel, L. M., Penner, L. A., Albrecht, T. L., Heath, E., Gwede, C. K., & Eggly, S. (2016). Barriers to Clinical Trial Enrollment in Racial and Ethnic Minority Patients With Cancer. Cancer Control: Journal of the Moffitt Cancer Center, 23(4), 327– 337. 10.1177/107327481602300404 [PMC free article: PMC5131730] [PubMed: 27842322] [CrossRef]

Hardie, G., Liu, R., Darden, J., & Gold, W. M. (2010). Ethnic differences in methacholine responsiveness and word descriptors in African Americans, Hispanic-Mexican Americans, Asian-Pacific Islanders, and Whites with mild asthma. The Journal of Asthma: Official Journal of the Association for the Care of Asthma, 47(4), 388–396. 10.3109/02770903.2010.481341 [PubMed: 20528591] [CrossRef]

Holmes, D. R., Major, J., Lyonga, D. E., Alleyne, R. S., & Clayton, S. M. (2012). Increasing minority patient participation in cancer clinical trials using oncology nurse navigation. American Journal of Surgery, 203(4), 415–422. 10.1016/j.amjsurg.2011.02.005 [PubMed: 21996347] [CrossRef]

Huey, R. W., George, G. C., Phillips, P., White, R., Fu, S., Janku, F., Karp, D. D., Naing, A., Piha-Paul, S., Subbiah, V., Tsimberidou, A. M., Pant, S., Yap, T. A., Rodon, J., Meric-Bernstam, F., Shih, Y.-C. T., & Hong, D. S. (2021). Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials. The Oncologist, 26(7), 588–596. 10.1002/onco.13767 [PMC free article: PMC8265355] [PubMed: 33783054] [CrossRef]

Kaasa, S., Bjordal, K., Aaronson, N., Moum, T., Wist, E., Hagen, S., & Kvikstad, A. (1995). The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. European journal of cancer (Oxford, England: 1990), 31A(13–14), 2260–2263. 10.1016/0959-8049(95)00296-0 [PubMed: 8652253] [CrossRef]

Kehl, K. L., Fullmer, C. P., Fu, S., George, G. C., Hess, K. R., Janku, F., Karp, D. D., Kato, S., Kizer, C. K., Kurzrock, R., Naing, A., Pant, S., Piha-Paul, S. A., Subbiah, V., Tsimberidou, A. M., & Hong, D. S. (2017). Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 23(15), 4155–4162. 10.1158/1078-0432.CCR-16-3027 [PMC free article: PMC5902668] [PubMed: 28729355] [CrossRef]

Keilson, J. M., Lindsey, S., Bachini, M., Medin, C. R., Berk, A., Cornew, S., & Maithel, S. K. (2022). Patient reported outcomes: Financial toxicity is a barrier to clinical trials and personalized therapy in cholangiocarcinoma. Journal of Surgical Oncology, 126(6), 1003–1010. 10.1002/jso.27012 [PMC free article: PMC9580504] [PubMed: 35839090] [CrossRef]

Kilgore, M. L., & Goldman, D. P. (2008). Drug costs and out-of-pocket spending in cancer clinical trials. Contemporary Clinical Trials, 29(1), 1–8. 10.1016/j.cct.2007.04.004 [PubMed: 17544339] [CrossRef]

King, A. C., Cao, D., Southard, C. C., & Matthews, A. (2011). Racial differences in eligibility and enrollment in a smoking cessation clinical trial. Health Psychology: Official Journal of the Division of Health Psychology, American Psychological Association, 30(1), 40–48. 10.1037/a0021649 [PMC free article: PMC3057492] [PubMed: 21299293] [CrossRef]

Kunos, C. A., & Abdallah, R. (2020). Financial Toxicity Encountered in Therapeutic Radiopharmaceutical Clinical Development for Ovarian Cancer. Pharmaceuticals (Basel, Switzerland), 13(8), 181. 10.3390/ph13080181 [PMC free article: PMC7464475] [PubMed: 32764223] [CrossRef]

Langford, A. T., Resnicow, K., Dimond, E. P., Denicoff, A. M., Germain, D. St., McCaskill-Stevens, W., Enos, R. A., Carrigan, A., Wilkinson, K., & Go, R. S. (2014). Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute’s Community Cancer Centers Program. Cancer, 120(6), 877–884. 10.1002/cncr.28483 [PMC free article: PMC3947654] [PubMed: 24327389] [CrossRef]

Largent, E. A., Heffernan, K. G., Joffe, S., & Lynch, H. F. (2020). Paying Clinical Trial Participants: Legal Risks and Mitigation Strategies. Journal of Clinical Oncology, 38(6), 532–537. 10.1200/JCO.19.00250 [PubMed: 31199697] [CrossRef]

Largent, E. A., & Lynch, H. F. (2018). Addressing Financial Barriers to Enrollment in Clinical Trials. JAMA Oncology, 4(7), 913–914. 10.1001/jamaoncol.2018.0492 [PubMed: 29710211] [CrossRef]

Lee, A., Shah, K., & Chino, F. (2020). Assessment of Parking Fees at National Cancer Institute–Designated Cancer Treatment Centers. JAMA Oncology, 6(8), 1295. 10.1001/jamaoncol.2020.1475 [PMC free article: PMC7366280] [PubMed: 32672809] [CrossRef]

Mackay, C. B., Gurley-Calvez, T., Erickson, K. D., & Jensen, R. A. (2016). Clinical trial insurance coverage for cancer patients under the Affordable Care Act. Contemporary Clinical Trials Communications, 2, 69–74. 10.1016/j.conctc.2015.12.002 [PMC free article: PMC5935846] [PubMed: 29736447] [CrossRef]

MacLennan, D. L., Plahovinsak, J. L., MacLennan, R. J., & Jones, C. T. (2023). Clinical Trial Site Perspectives and Practices on Study Participant Diversity and Inclusion. Clinical Pharmacology & Therapeutics, 113(3), 670–679. 10.1002/cpt.2817 [PubMed: 36495475] [CrossRef]

Manne, S., Kashy, D., Albrecht, T., Wong, Y.-N., Lederman Flamm, A., Benson, A. B., Miller, S. M., Fleisher, L., Buzaglo, J., Roach, N., Katz, M., Ross, E., Collins, M., Poole, D., Raivitch, S., Miller, D. M., Kinzy, T. G., Liu, T., & Meropol, N. J. (2015). Attitudinal barriers to participation in oncology clinical trials: Factor analysis and correlates of barriers. European Journal of Cancer Care, 24(1), 28–38. 10.1111/ecc.12180 [PMC free article: PMC4417937] [PubMed: 24467411] [CrossRef]

Martin, P. J., Davenport-Ennis, N., Petrelli, N. J., Stewart, F. M., Appelbaum, F. R., & Benson, A. (2014). Responsibility for Costs Associated With Clinical Trials. Journal of Clinical Oncology, 32(30), 3357–3359. 10.1200/JCO.2014.57.1422 [PMC free article: PMC4876354] [PubMed: 25225433] [CrossRef]

Masoli, J. A. H., Down, K., Nestor, G., Hudson, S., O’Brien, J. T., Williamson, J. D., Young, C. A., Carroll, C., & NIHR Remote Trial Delivery Working Group. (2021). A report from the NIHR UK working group on remote trial delivery for the COVID-19 pandemic and beyond. Trials, 22(1), 911. 10.1186/s13063-021-05880-8 [PMC free article: PMC8665850] [PubMed: 34895305] [CrossRef]

McElfish, P. A., Long, C. R., Selig, J. P., Rowland, B., Purvis, R. S., James, L., Holland, A., Felix, H. C., & Narcisse, M. (2018). Health Research Participation, Opportunity, and Willingness Among Minority and Rural Communities of Arkansas. Clinical and Translational Science, 11(5), 487–497. 10.1111/cts.12561 [PMC free article: PMC6132365] [PubMed: 29772113] [CrossRef]

Medina, S. P., Zhang, S., Nieves, E., Dornsife, D. L., Johnson, R., Spicer, D., & Borno, H. T. (2023). Experiences of a Multiethnic Cohort of Patients Enrolled in a Financial Reimbursement Program for Cancer Clinical Trials. JCO Oncology Practice, 19(5), e801–e810. 10.1200/OP.22.00429 [PubMed: 36800640] [CrossRef]

Mupfudze, T. G., Preussler, J. M., Sees, J. A., SanCartier, M., Arnold, S. D., & Devine, S. (2021). A Qualitative Analysis of State Medicaid Coverage Benefits for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Patients with Sickle Cell Disease (SCD). Transplantation and Cellular Therapy, 27(4), 345–351. 10.1016/j.jtct.2021.01.022 [PubMed: 33836889] [CrossRef]

Murphy, A. L., Turner, J. P., Rajda, M., Allen, K. G., Pinter, K., & Gardner, D. M. (2023). Effectiveness and cost analysis of methods used to recruit older adult sedative users to a deprescribing randomized controlled trial during the COVID-19 pandemic. Exploratory Research in Clinical and Social Pharmacy, 9, 100214. 10.1016/j.rcsop.2022.100214 [PMC free article: PMC9751000] [PubMed: 36540425] [CrossRef]

National Academies of Sciences, Engineering, and Medicine. 2022. Improving Representation in Clinical Trials and Research: Building Research Equity for Women and Underrepresented Groups. Washington, DC: The National Academies Press. 10.17226/26479. [PubMed: 36137057] [CrossRef]

Nipp, R. D., Hong, K., & Paskett, E. D. (2019). Overcoming Barriers to Clinical Trial Enrollment. American Society of Clinical Oncology Educational Book, 39, 105–114. 10.1200/EDBK_243729 [PubMed: 31099636] [CrossRef]

Nipp, R. D., Lee, H., Gorton, E., Lichtenstein, M., Kuchukhidze, S., Park, E., Chabner, B. A., & Moy, B. (2019). Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity Intervention. The Oncologist, 24(8), 1048–1055. 10.1634/theoncologist.2019-0146 [PMC free article: PMC6693715] [PubMed: 30988039] [CrossRef]

Nipp, R. D., Lee, H., Powell, E., Birrer, N. E., Poles, E., Finkelstein, D., Winkfield, K., Percac-Lima, S., Chabner, B., & Moy, B. (2016). Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity Program. The Oncologist, 21(4), 467–474. 10.1634/theoncologist.2015-0481 [PMC free article: PMC4828126] [PubMed: 26975867] [CrossRef]

Nipp, R. D., Powell, E., Chabner, B., & Moy, B. (2015). Recognizing the Financial Burden of Cancer Patients in Clinical Trials. The Oncologist, 20(6), 572–575. 10.1634/theoncologist.2015-0068 [PMC free article: PMC4571792] [PubMed: 25986245] [CrossRef]

Olivier, T., Haslam, A., & Prasad, V. (2023). Is financial toxicity captured in quality of life assessments in oncology randomized clinical trials? Journal of Cancer Policy, 36, 100423. 10.1016/j.jcpo.2023.100423 [PubMed: 37075841] [CrossRef]

Paidipati, C. P., Foxwell, A. M., Mooney-Doyle, K., Tiller, D., Pinto-Martin, J., & Ulrich, C. M. (2023). Caregiver Perspectives on the Benefits, Burdens, and Moral Distress of Participation in Cancer Clinical Trials. Journal of Family Nursing, 29(1), 89–98. 10.1177/10748407221098187 [PubMed: 35611586] [CrossRef]

Perni, S., Azoba, C., Gorton, E., Park, E. R., Chabner, B. A., Moy, B., & Nipp, R. D. (2022). Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial Participants. JCO Oncology Practice, 18(9), e1427–e1437. 10.1200/OP.21.00697 [PubMed: 35666957] [CrossRef]

Perni, S., Moy, B., & Nipp, R. D. (2021). Disparities in phase 1 cancer clinical trial enrollment. Cancer, 127(23), 4464– 4469. 10.1002/cncr.33853 [PubMed: 34379799] [CrossRef]

Pisu, M., Azuero, A., Meneses, K., Burkhardt, J., & McNees, P. (2011). Out of pocket cost comparison between Caucasian and minority breast cancer survivors in the Breast Cancer Education Intervention (BCEI). Breast Cancer Research and Treatment, 127(2), 521–529. 10.1007/s10549-010-1225-0 [PMC free article: PMC3087852] [PubMed: 20976542] [CrossRef]

Popkin, R., Taylor-Zapata, P., & Bianchi, D. W. (2022). Physician Bias and Clinical Trial Participation in Underrepresented Populations. Pediatrics, 149(2), e2021054150. 10.1542/peds.2021-054150 [PMC free article: PMC10100134] [PubMed: 35043204] [CrossRef]

Prasad, R. N., Royce, T. J., Chino, F., Jagsi, R., & Palmer, J. D. (2022). Financial Toxicity as an End Point in Prospective Clinical Trials Involving Radiation Therapy. Advances in Radiation Oncology, 7(6), 100970. 10.1016/j.adro.2022.100970 [PMC free article: PMC9126781] [PubMed: 35620674] [CrossRef]

Raciborski, R. A., Hamerling-Potts, K. K., Mitchell, E. L., Sullivan, S. R., Kapil-Pair, N., Landes, S. J., Jager-Hyman, S., & Goodman, M. (2023). Cost comparison of in-person and telehealth modalities for a suicide safety planning group intervention: Interim results from the “Project Life Force” randomized clinical trial. Frontiers in Psychiatry, 14, 1215247. 10.3389/fpsyt.2023.1215247 [PMC free article: PMC10617511] [PubMed: 37915795] [CrossRef]

Reoma, L. B., & Karp, B. I. (2022). The Human Cost: Patient Contribution to Clinical Trials in Neurology. Neurotherapeutics: The Journal of the American Society for Experimental NeuroTherapeutics, 19(5), 1503–1506. 10.1007/s13311-022-01292-x [PMC free article: PMC9606162] [PubMed: 36083396] [CrossRef]

Riaz, I. B., Islam, M., Ikram, W., Naqvi, S. A. A., Maqsood, H., Saleem, Y., Riaz, A., Ravi, P., Wang, Z., Hussain, S. A., Warner, J. L., Odedina, F. T., Duma, N., Singh, P., Kehl, K. L., Kamran, S. C., Murad, M. H., Landman, A., Van Allen, E., & Bryce, A. H. (2023). Disparities in the Inclusion of Racial and Ethnic Minority Groups and Older Adults in Prostate Cancer Clinical Trials: A Meta-analysis. JAMA Oncology, 9(2), 180–187. 10.1001/jamaoncol.2022.5511 [PMC free article: PMC9685549] [PubMed: 36416812] [CrossRef]

Rocque, G. B., Andrews, C., Lawhon, V. M., Frazier, R., Ingram, S. A., Smith, M. L., Wagner, L. I., Zubkoff, L., Tung, N., Wallner, L. P., & Wolff, A. C. (2023). Oncologist-Reported Barriers and Facilitators to Enrolling Patients in Optimization Trials That Test Less Intense Cancer Treatment. JCO Oncology Practice, 19(2), e263–e273. 10.1200/OP.22.00472 [PubMed: 36473142] [CrossRef]

Sehrawat, O., Noseworthy, P. A., Siontis, K. C., Haddad, T. C., Halamka, J. D., & Liu, H. (2023). Data-Driven and Technology-Enabled Trial Innovations Toward Decentralization of Clinical Trials: Opportunities and Considerations. Mayo Clinic Proceedings, 98(9), 1404–1421. 10.1016/j.mayocp.2023.02.003 [PubMed: 37661149] [CrossRef]

Sidana, S., Allmer, C., Larson, M. C., Dueck, A., Yost, K., Warsame, R., Thanarajasingam, G., Cerhan, J. R., Paludo, J., Rajkumar, S. V., Habermann, T. M., Nowakowski, G. S., Lin, Y., Gertz, M. A., Witzig, T., Dispenzieri, A., Gonsalves, W. I., Ansell, S. M., Thompson, C. A., & Kumar, S. K. (2022). Patient Experience in Clinical Trials: Quality of Life, Financial Burden, and Perception of Care in Patients With Multiple Myeloma or Lymphoma Enrolled on Clinical Trials Compared With Standard Care. JCO Oncology Practice, 18(8), e1320–e1333. 10.1200/OP.21.00789 [PMC free article: PMC9377715] [PubMed: 35580285] [CrossRef]

Tan, A. C., Ashley, D. M., & Khasraw, M. (2020). Adapting to a Pandemic—Conducting Oncology Trials during the SARS-CoV-2 Pandemic. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 26(13), 3100–3103. 10.1158/1078-0432.CCR-20-1364 [PMC free article: PMC7357670] [PubMed: 32312892] [CrossRef]

Thetford, K., Gillespie, T. W., Kim, Y., Hansen, B., & Scarinci, I. C. (n.d.). Willingness of Latinx and African Americans to Participate in Nontherapeutic Trials: It Depends on Who Runs the Research. Ethnicity & Disease, 31(2), 263–272. https://pubmed​.ncbi.nlm​.nih.gov/33883867/ [PMC free article: PMC8054877] [PubMed: 33883867]

Unger, J. M., & Fleury, M. E. (2019). Reimbursing Patients for Participation in Cancer Clinical Trials. JAMA Oncology, 5(7), 932–934. 10.1001/jamaoncol.2019.0141 [PubMed: 31169875] [CrossRef]

Unger, J. M., Gralow, J. R., Albain, K. S., Ramsey, S. D., & Hershman, D. L. (2016). Patient Income Level and Cancer Clinical Trial Participation in a Prospective Survey Study. JAMA Oncology, 2(1), 137–139. 10.1001/jamaoncol.2015.3924 [PMC free article: PMC4824189] [PubMed: 26468994] [CrossRef]

Unger, J. M., Hershman, D. L., Albain, K. S., Moinpour, C. M., Petersen, J. A., Burg, K., & Crowley, J. J. (2013). Patient Income Level and Cancer Clinical Trial Participation. Journal of Clinical Oncology, 31(5), 536–542. 10.1200/JCO.2012.45.4553 [PMC free article: PMC3565180] [PubMed: 23295802] [CrossRef]

Unger, J. M., Xiao, H., Vaidya, R., LeBlanc, M., & Hershman, D. L. (2023). Medicaid Expansion of the Patient Protection and Affordable Care Act and Participation of Patients With Medicaid in Cancer Clinical Trials. JAMA Oncology, 9(10), 1371–1379. 10.1001/jamaoncol.2023.2800 [PMC free article: PMC10436183] [PubMed: 37590003] [CrossRef]

Virani, S., Burke, L., Remick, S. C., & Abraham, J. (2011). Barriers to Recruitment of Rural Patients in Cancer Clinical Trials. Journal of Oncology Practice, 7(3), 172–177. 10.1200/JOP.2010.000158 [PMC free article: PMC3092658] [PubMed: 21886499] [CrossRef]

Walter, J. K., Burke, J. F., & Davis, M. M. (2013). Research Participation by Low-Income and Racial/Ethnic Minority Groups: How Payment May Change the Balance. Clinical and Translational Science, 6(5), 363–371. 10.1111/cts.12084 [PMC free article: PMC5350891] [PubMed: 24127923] [CrossRef]

Ward, E., Jemal, A., Cokkinides, V., Singh, G. K., Cardinez, C., Ghafoor, A., & Thun, M. (2004). Cancer disparities by race/ethnicity and socioeconomic status. CA: A Cancer Journal for Clinicians, 54(2), 78–93. 10.3322/canjclin.54.2.78 [PubMed: 15061598] [CrossRef]

Williams, C. P., Geiger, A. M., Norton, W. E., de Moor, J. S., & Everson, N. S. (2023). Influence of Cost-Related Considerations on Clinical Trial Participation: Results from the 2020 Health Information National Trends Survey (HINTS). Journal of General Internal Medicine, 38(5), 1200–1206. 10.1007/s11606-022-07801-0 [PMC free article: PMC9713084] [PubMed: 36451016] [CrossRef]

Williams, C. P., Senft Everson, N., Shelburne, N., & Norton, W. E. (2021). Demographic and Health Behavior Factors Associated With Clinical Trial Invitation and Participation in the United States. JAMA Network Open, 4(9), e2127792. 10.1001/jamanetworkopen.2021.27792 [PMC free article: PMC8482053] [PubMed: 34586365] [CrossRef]

Williams, M. J., Okai, A. F., Cross, A. H., Monson, N. L., Vartanian, T., Thrower, B. W., Reder, A. T., English, J. B., Wu, G. F., Bernitsas, E., Yap, S., Ndrio, J., Pei, J., Mowry, E. M., Magrini, F., Acosta, J., & Amezcua, L. (2023). Demographics and baseline disease characteristics of Black and Hispanic patients with multiple sclerosis in the open-label, single-arm, multicenter, phase IV CHIMES trial. Multiple Sclerosis and Related Disorders, 76, 104794. 10.1016/j.msard.2023.104794 [PubMed: 37356256] [CrossRef]

Winkfield, K. M. (2020). Improving access to cancer clinical trials by reducing the financial burden. Cancer, 126(1), 14– 16. 10.1002/cncr.32523 [PubMed: 31581309] [CrossRef]

Winkfield, K. M., Phillips, J. K., Joffe, S., Halpern, M. T., Wollins, D. S., & Moy, B. (2018). Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy Statement. Journal of Clinical Oncology, 36(33), 3331–3339. 10.1200/JCO.18.01132 [PubMed: 30212297] [CrossRef]

Wong, Y.-N., Schluchter, M. D., Albrecht, T. L., Benson, A. B., Buzaglo, J., Collins, M., Flamm, A. L., Fleisher, L., Katz, M., Kinzy, T. G., Liu, T. M., Manne, S., Margevicius, S., Miller, D. M., Miller, S. M., Poole, D., Raivitch, S., Roach, N., Ross, E., & Meropol, N. J. (2016). Financial Concerns About Participation in Clinical Trials Among Patients With Cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 34(5), 479–487. 10.1200/JCO.2015.63.2463 [PMC free article: PMC4872013] [PubMed: 26700120] [CrossRef]